98 results
Page 4 of 5
8-K
EX-99.2
j5y fvk57d6aic8ll5m
16 Oct 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
hiz rieh4e9sh19s
16 Oct 15
Regulation FD Disclosure
12:00am
424B5
h83 8frzqwulc851
11 Dec 14
Prospectus supplement for primary offering
12:00am
424B5
2w5jxgfq
9 Dec 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
23e7hj3v32nrt 6uxm4m
8 Dec 14
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
12:00am
8-K
EX-99.1
wbnj79w71 tlso1
8 Dec 14
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
12:00am
8-K
EX-99.1
h6zryr56vh zojst
8 Dec 14
Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016
12:00am
8-K
8u35r3v2bgbvbp
19 Nov 14
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120
12:00am
8-K
EX-99.1
pqae01
19 Nov 14
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120
12:00am
8-K
EX-99.1
petu5 sqcqkkq
7 Nov 14
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
9hzri
15 Oct 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
9wn1r6k
7 Aug 14
Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results
12:00am